Nexletol

Esperion’s ‘lipid lurkers’ take on cardiovascular disease
Medical Marketing and Media
Tue, 07/16/24 - 12:04 pm
Esperion Therapeutics
Nexlizet
Nexletol
DTC advertising
Esperion Targets Seven-Fold Jump in Cholesterol Drug Population with FDA Label Expansion
BioSpace
Mon, 03/25/24 - 11:19 am
Esperion Therapeutics
cholesterol
Nexletol
Nexlizet
FDA
Esperion, Daiichi Sankyo milestone payment feud heats up with new lawsuit
Fierce Pharma
Tue, 03/28/23 - 10:57 pm
Esperion Therapeutics
Daiichi Sankyo
Nexletol
SEC
Daiichi torches Esperion’s Nexletol milestone promises
EP Vantage
Fri, 03/17/23 - 10:10 am
Daiichi Sankyo
Esperion Therapeutics
Nexletol
ACC 2023 – Esperion’s outcomes win looks lacklustre
EP Vantage
Mon, 03/6/23 - 10:45 am
Esperion Therapeutics
ACC
Nexletol
cholesterol
Esperion gets out the budget ax, chopping 170 staffers as its big drug launch sputters
Endpoints
Mon, 10/18/21 - 11:12 am
Esperion Therapeutics
layoffs
FDA
Nexletol
bempadoic acid
Esperion strikes Japan deal for 'goldilocks' cholestrol drug, bags $60M cash as pandemic forces virtual US rollout
Endpoints
Mon, 04/20/20 - 10:37 am
Esperion
Nexletol
Nexlizet
Japan
cholesterol
ACC: Esperion's Nexletol busts cholesterol levels regardless of statin, ezitimibe therapy
Fierce Pharma
Sat, 03/28/20 - 11:37 pm
ACC
Esperion
Nexletol
clinical trials
c-reactive protein
Esperion shifts to show not tell
EP Vantage
Tue, 02/25/20 - 10:21 am
Esperion Therapeutics
bempedoic acid
Nexletol
Esperion adds more competition to cholesterol drug market with newly approved drug
BioPharma Dive
Fri, 02/21/20 - 11:57 pm
Esperion Therapeutics
cholesterol
bempedoic acid
FDA
Nexletol